Date Field | Doc. No. | Description (Pages) |
---|
Jun 20, 2023 | 5 | NOTICE that this case has been assigned to Paul L. Maloney (eod) (Entered: 06/20/2023) (1) |
Jun 20, 2023 | 6 | REPORT from the Clerk, WDMI, to the Director of the U.S. Patent and Trademark Office on the filing of a PATENT ACTION (eod) (Entered: 06/20/2023) (30) |
Jun 20, 2023 | N/A | SUMMONS NOT ISSUED as to defendants Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC (none provided) (eod) (Entered: 06/20/2023) (0) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Main Document) (18) |
Jun 16, 2023 | N/A | FILING FEE PAID re 1 by plaintiff Hikma Pharmaceuticals USA Inc. in the amount of $402, receipt number AMIWDC-7087268 (Ahmad, Scott) (Entered: 06/16/2023) (0) |
Jun 16, 2023 | 2 | CORPORATE DISCLOSURE STATEMENT by Hikma Pharmaceuticals USA Inc. identifying Corporate Parent Hikma Pharmaceuticals PLC for Hikma Pharmaceuticals USA Inc. (Ahmad, Scott) (Entered: 06/16/2023) (2) |
Jun 16, 2023 | 3 | PROPOSED NOTICE Report on the Filing of an Action Regarding a Patent or Trademark by plaintiff Hikma Pharmaceuticals USA Inc. (Ahmad, Scott) Modified text on 6/20/2023 (eod) (Entered: 06/16/2023) (1) |
Jun 16, 2023 | 4 | NOTICE of Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) by plaintiff Hikma Pharmaceuticals USA Inc. (Ahmad, Scott) (Entered: 06/16/2023) (1) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Exhibit A) (23) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Exhibit B) (30) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Exhibit C) (30) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Exhibit D) (30) |
Jun 16, 2023 | 1 | COMPLAINT against Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) (Ahmad, Scott) (Entered: 06/16/2023) (Exhibit E) (30) |